This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (397) Mobile Health (mhealth) (1918) Alcohol Abuse, Alcoholism Prevention and Recovery (243) Substance Abuse (271) mHealth for Wellness, Behavior Change and Prevention (2268) Cost-Effectiveness and Economics (183)

Published on in Vol 11 , No 2 (2022) :February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31109, first published .
Testing an mHealth System for Individuals With Mild to Moderate Alcohol Use Disorders: Protocol for a Type 1 Hybrid Effectiveness-Implementation Trial

Testing an mHealth System for Individuals With Mild to Moderate Alcohol Use Disorders: Protocol for a Type 1 Hybrid Effectiveness-Implementation Trial

Testing an mHealth System for Individuals With Mild to Moderate Alcohol Use Disorders: Protocol for a Type 1 Hybrid Effectiveness-Implementation Trial

Authors of this article:

Linda S Park 1 Author Orcid Image ;   Ming-Yuan Chih 2 Author Orcid Image ;   Christine Stephenson 3 Author Orcid Image ;   Nicholas Schumacher 1 Author Orcid Image ;   Randall Brown 1 Author Orcid Image ;   David Gustafson 4 Author Orcid Image ;   Bruce Barrett 1 Author Orcid Image ;   Andrew Quanbeck 1 Author Orcid Image
Article Authors Cited by (3) Tweetations (4) Metrics

Journals

  1. Glass J, Dorsey C, Beatty T, Bobb J, Wong E, Palazzo L, King D, Mogk J, Stefanik-Guizlo K, Idu A, Key D, Fortney J, Thomas R, McWethy A, Caldeiro R, Bradley K. Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial). Implementation Science 2023;18(1) View
  2. Manning V, Whelan D, Piercy H. The current evidence for substance use disorder apps. Current Opinion in Psychiatry 2022;35(4):237 View
  3. Ford J, Cheng H, Gassman M, Fontaine H, Garneau H, Keith R, Michael E, McGovern M. Stepped implementation-to-target: a study protocol of an adaptive trial to expand access to addiction medications. Implementation Science 2022;17(1) View